Literature DB >> 26132601

Cancer as the Disintegration of Robustness: Population-Level Variance in Gene Expression Identifies Key Differences Between Tobacco- and HPV-Associated Oropharyngeal Carcinogenesis.

Miriam M Ben-Dayan, Thomas MacCarthy, Nicolas F Schlecht, Thomas J Belbin, Geoffrey Childs, Richard V Smith, Michael B Prystowsky, Aviv Bergman1.   

Abstract

CONTEXT: Oropharyngeal squamous cell carcinoma is associated both with tobacco use and with human papillomavirus (HPV) infection. It is argued that carcinogen-driven tumorigenesis is a distinct disease from its virally driven counterpart. We hypothesized that tumorigenesis is the result of a loss of genotypic robustness resulting in an increase in phenotypic variation in tumors compared with adjacent histologically normal tissues, and that carcinogen-driven tumorigenesis results in greater variation than its virally driven counterpart.
OBJECTIVES: To examine the loss of robustness in carcinogen-driven and virally driven oropharyngeal squamous cell carcinoma samples, and to identify potential pathways involved.
DESIGN: We used coefficients of variation for messenger RNA and microRNA expression to measure the loss of robustness in oropharyngeal squamous cell carcinoma samples. Tumors were compared with matched normal tissues, and were further categorized by HPV and patient smoking status. Weighted gene coexpression networks were constructed for genes with highly variable expression among the HPVtumors from smokers.
RESULTS: We observed more genes with variable messenger RNA expression in tumors compared with normal tissues, regardless of HPV and smoking status, and more microRNAs with variable expression in HPV⁻ and HPVtumors from smoking patients than from nonsmokers. For both the messenger RNA and microRNA data, we observed more variance among HPVtumors from smokers compared with HPVtumors from nonsmokers. The gene coexpression network construction highlighted pathways that have lost robustness in carcinogen-induced tumors but appear stable in virally induced tumors.
CONCLUSIONS: Using coefficients of variation and coexpression networks, we identified multiple altered pathways that may play a role in carcinogen-driven tumorigenesis.

Entities:  

Mesh:

Year:  2015        PMID: 26132601      PMCID: PMC5695554          DOI: 10.5858/arpa.2014-0624-OA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  59 in total

1.  Deep-sequencing of endothelial cells exposed to hypoxia reveals the complexity of known and novel microRNAs.

Authors:  Christine Voellenkle; Jeroen van Rooij; Alessandro Guffanti; Elena Brini; Pasquale Fasanaro; Eleonora Isaia; Larry Croft; Matei David; Maurizio C Capogrossi; Anna Moles; Armando Felsani; Fabio Martelli
Journal:  RNA       Date:  2012-01-26       Impact factor: 4.942

2.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

Review 3.  Experimental validation of miRNA targets.

Authors:  Donald E Kuhn; Mickey M Martin; David S Feldman; Alvin V Terry; Gerard J Nuovo; Terry S Elton
Journal:  Methods       Date:  2008-01       Impact factor: 3.608

4.  Evolution and classification of oncogenic human papillomavirus types and variants associated with cervical cancer.

Authors:  Zigui Chen; Luciana Bueno de Freitas; Robert D Burk
Journal:  Methods Mol Biol       Date:  2015

Review 5.  Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review.

Authors:  Aimee R Kreimer; Gary M Clifford; Peter Boyle; Silvia Franceschi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

Review 6.  Epithelial-mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells.

Authors:  Magdalena Książkiewicz; Aleksandra Markiewicz; Anna J Zaczek
Journal:  Pathobiology       Date:  2012-04-04       Impact factor: 4.342

Review 7.  Human papillomavirus in HNSCC: recognition of a distinct disease type.

Authors:  Laura Vidal; Maura L Gillison
Journal:  Hematol Oncol Clin North Am       Date:  2008-12       Impact factor: 3.722

Review 8.  Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives.

Authors:  H Mirghani; F Amen; P Blanchard; F Moreau; J Guigay; D M Hartl; J Lacau St Guily
Journal:  Int J Cancer       Date:  2014-04-04       Impact factor: 7.396

9.  Expression of EGFR, VEGF, and NOTCH1 suggest differences in tumor angiogenesis in HPV-positive and HPV-negative head and neck squamous cell carcinoma.

Authors:  Jesse D Troy; Joel L Weissfeld; Ada O Youk; Sufi Thomas; Lin Wang; Jennifer R Grandis
Journal:  Head Neck Pathol       Date:  2013-05-04

Review 10.  Somatic evolution of head and neck cancer - biological robustness and latent vulnerability.

Authors:  Muneyuki Masuda; Satoshi Toh; Takahiro Wakasaki; Masumi Suzui; Andrew K Joe
Journal:  Mol Oncol       Date:  2012-11-02       Impact factor: 6.603

View more
  3 in total

Review 1.  In silico methods for drug repurposing and pharmacology.

Authors:  Rachel A Hodos; Brian A Kidd; Khader Shameer; Ben P Readhead; Joel T Dudley
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-04-15

2.  Association of miR-1247-5p expression with clinicopathological parameters and prognosis in breast cancer.

Authors:  Peng Zhang; Changsheng Fan; Jun Du; Xueli Mo; Qikang Zhao
Journal:  Int J Exp Pathol       Date:  2018-09-03       Impact factor: 1.925

3.  Targeted MicroRNA Profiling in Gastric Cancer with Clinical Assessement.

Authors:  H Pehlevan Özel; T Dinç; R S Tiryaki; A G Keşküş; Ö Konu; S I Kayilioğlu; F Coşkun
Journal:  Balkan J Med Genet       Date:  2022-06-05       Impact factor: 0.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.